It was 2023 when Robert F. Kennedy Jr. was seen on video with a group of his colleagues telling the world that COVID–19 was created to destroy White and Black folks.
Back then, Kennedy was a Democratic presidential candidate hoping to hang his coat in the Oval Office of the white house. A lot has happened since then, and Kennedy went from being against the so-called COVID Vaccine to supporting it. In fact, one of the conditions of his becoming the HHS (Health and Human Services boss) was that he would not speak against what Big Pharma calls the vaccine.
Fast forward to today, this 2023 video is now trending on Twitter with leading star Robert F. Kennedy Jr spilling the vaccine beans. In this video, Kennedy goes off on the depopulation planners, including his own country, the USA. “We need to talk about Bioweapons; I know a lot about Bioweapons because I have been doing a book about it for two and a half years now. The technology that we now have has put hundreds of thousands of dollars into ethnically targeted microbes.”
“The Chinese have done the same thing. In fact, COVID-19 is an argument that it is ethnically targeted. COVID-19 attacks certain races disproportionately. The races that are most immune to COVID-19 are because of the structure, or genetic direct structure, different races have different receptors of the ACE2 receptor, COVID-19 targets Caucasians and Black people.”
Kennedy went on to say, “The people most immune are Ashkenazi Jews and Chinese. We do not know if it was deliberately targeted, but there are papers out there that show the racial and ethnic differences and impact. We do know that the Chinese are spending hundreds of millions of dollars developing ethnic bioweapons, and we are developing ethnic Bioweapons.”
“That is what all those labs in Ukraine are about. There are collecting Russian DNA, collection Chinese DNA so that we can target people by race.”
For anyone interested in looking into this subject, here are a few study links, complete with maps that illustrate.
Stay in the loop with exclusive news, stories, and insights—delivered straight to your inbox. No fluff, just real content that matters. Sign up today!
